CELU Celularity Inc Net earnings per share growth forecast for next year
Celularity Inc. integrates ESG standards into bioethics and data security. Analyst expectations for N+1 profit dynamics visualize market demand, where 0.00 serves as the current metric level. Supplies of orthopedic materials are currently acting as a cash generator, while breakthroughs in oncology are expected later. Growth prospects are based on insurance reimbursements for regenerative drugs derived from placental cells.
Metric breakdowns and analytics for Celularity (CELU)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
- earnings and valuation multiples information:
CELU - Net Profit|Expected Profit Celularity Inc.|CELU - Company Value to Net Income|Forward P/E Multiple Celularity Inc|CELU - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Celularity|CELU - Company profit before taxes, interest and amortization|Net earnings per share for the last 12 months Celularity|CELU - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months celularity.com|CELU - Earnings per share increase in current year|Earnings growth forecast for next year Celularity Inc.
Summary company analysis:Celularity Inc.
The success of Celularity Inc. (CELU) is determined by clinical trial outcomes, rendering the business independent of market cycles. The mathematical basis of the metric reflects the issuer's ability to generate cash flow, accounting for debt obligations and inflation over a one-year horizon. By analyzing the projected profit growth for the coming year, an investor assesses the company's solvency and the dynamics of revised expectations from the expert community.
Main competitors
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|Grifols Biemat (GRFS) - Expected earnings per share growth for next year|ADPT: Earnings growth forecast for next year|Expected net earnings per share growth next year celldex.com (CLDX)|Net earnings per share growth forecast for next year Aurinia Pharmaceuticals Inc.|Net earnings per share growth forecast for next year BCRX|Expected earnings per share growth for next year VERA (Vera Pharma)|Earnings growth forecast for next year Dianthus Corp (DNTH)|Net earnings per share growth forecast for next year Pharvaris N.V. PHVS|abcellera.com - Net earnings per share growth forecast for next year|Tourmaline Bio - Earnings growth forecast for next year|PGEN - Earnings growth forecast for next year|Pharming (PHAR) - Net earnings per share growth forecast for next year|Nektar Corp - Expected earnings per share trend next year|UPB (Upstream Bio Inc) - Earnings growth forecast for next year|zenasbio.com (ZBIO) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year IMNM (Immunome)|Projected earnings per share increase next year GOSS|KalVista Pharmaceuticals Inc - Expected earnings per share growth for next year|Septerna Pharma (SEPN) - Expected net earnings per share growth next year|PVLA: Expected earnings per share growth for next year|Expected earnings per share trend next year SVRA (savarapharma.com)|RIGL: Earnings growth forecast for next year|ANAB - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Astria Pharma|Projected earnings per share growth rate for next year ENGN (enGene Corp)|Earnings growth forecast for next year RAPT|Expected earnings per share growth for next year aerovatetx.com JBIO|Aclaris Therapeutics, Inc. - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Kyverna Therapeutics Inc. (KYTX)|Tiziana Life Sciences PLC - Earnings growth forecast for next year|Cabaletta Bio Inc (CABA) - Expected earnings per share growth for next year|VTYX: Earnings growth forecast for next year|Expected net earnings per share growth next year theratech.com (THTX)|Net earnings per share growth forecast for next year Avalo Therapeutics|Net earnings per share growth forecast for next year ELDN|Expected earnings per share growth for next year AGEN (Agenus Inc)|Earnings growth forecast for next year Climb Bio, Inc (CLYM)|Net earnings per share growth forecast for next year Zura Bio Limited ZURA|ATYR (atyrpharma.com) - Net earnings per share change forecast for next year|Adagene Corp - Earnings growth forecast for next year|Expected earnings per share trend next year IMA (ImageneBio Inc)|STTK: Earnings growth forecast for next year|Equillium (EQ) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Connect Biopharma Holdings|IMUX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Atara Biotherapeutics (ATRA)|Expected earnings per share growth for next year inflarx.de IFRX|Earnings growth forecast for next year XFOR (X4 Pharma)|Earnings growth forecast for next year Adicet Bio Inc. ACET|INMB: Expected earnings per share growth for next year|Expected earnings per share trend next year BRNS (barinthusbio.com)|KZR: Earnings growth forecast for next year|SABS - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Akari Therapeutics plc|Expected earnings per share growth for next year Enlivex Therapeutics, Ltd. (ENLV)|Net earnings per share growth forecast for next year Q32 Bio Inc. (QTTB)|Expected earnings per share growth for next year geovax.com GOVX|Edesa Biotech - Expected earnings per share growth for next year|Earnings growth forecast for next year iBio Inc IBIO|CARM - Net earnings per share growth forecast for next year|XTLB (XTL Bio) - Projected earnings per share growth rate for next year|BOLT: Earnings growth forecast for next year|Expected net earnings per share growth next year HCW Biologics (HCWB)|APVO (Aptevo Therapeutics, Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year AIM ImmunoTech, Inc. (AIM)|Earnings growth forecast for next year ADTX|GRI - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year XORTX Therapeutics Inc. XRTX|reshapelifesciences.com - Net earnings per share growth forecast for next year|REVB: Expected earnings per share growth for next year|INDP - Earnings growth forecast for next year|Scinai (SCNI) - Net earnings per share growth forecast for next year|CALI (CalciMedica) - Net earnings per share growth forecast for next year|AFMD (Affimed NV) - Earnings growth forecast for next year|Earnings growth forecast for next year Allakos Therapeutics|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|IGMS (igmbio.com) - Expected earnings per share trend next year|Earnings growth forecast for next year ITOS (iTeos)|Consensus forecast of earnings per share growth for next year Ocean Biomedical Corp (OCEA)|TCBP: Expected earnings per share growth for next year|thirdharmonicbio.com - Projected earnings per share increase next year
